LANVIS 40 mg, scored tablet 25 tablets
Active ingredients: Thioguanosine
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet25 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LANVIS 40 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- flacon(s) en verre brun de 25 comprimé(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Sept 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66827036CIP73692300CIP133400936923003Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| THIOGUANINEcomprimé | 40 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.